Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.8003
+0.0243 (3.13%)
At close: Sep 29, 2026, 4:00 PM EDT
0.8183
+0.0180 (2.25%)
After-hours: Sep 29, 2026, 7:30 PM EDT

RANI Revenue

Rani Therapeutics Holdings had revenue of $1.71M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $4.88M, up 306.42% year-over-year. In the year 2025, Rani Therapeutics Holdings had annual revenue of $1.63M with 58.85% growth.

Revenue (ttm)
$4.88M
Revenue Growth
+306.42%
P/S Ratio
22.87
Revenue / Employee
$68,690
Employees
71
Market Cap
111.56M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.63M605.00K58.85%
Dec 31, 20241.03M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 20212.72M2.26M488.10%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Black Diamond Therapeutics70.00M
Seer, Inc.14.22M
Coya Therapeutics8.02M
Milestone Pharmaceuticals2.34M
Inovio Pharmaceuticals65.34K
Genelux8.00K
Revenue Rankings

RANI News

More News